Four drugs recommended for approval by CHMP at April meeting

A total of 29 drugs have been recommended for approval in the EU so far in 2022, after four drugs were added to the mix during this month’s meeting of the CHMP, the EMA’s expert committee.

Photo: Peter Dejong/AP/Ritzau Scanpix

At its meeting in April, the European Medicines Agency’s (EMA) expert committee, the CHMP, has given a positive opinion on four drugs for European use, and has recommended extensions to the indications of an additional seven medicines.

The Committee for Medicinal Products for Human Use has given its regulatory thumbs-up to British firm Amryt Pharmaceuticals, which was seeking the committee’s approval for drug Filsuvez (birch bark extract) for the treatment of epidermolysis bullosa, a group of rare diseases that cause blistering skin and can be fatal in the most severe cases.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs